BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 2952797)

  • 41. [Complications of D-penicillamine treatment of rheumatoid poly-arthritis].
    Camus JP; Crouzet J; Prier A; Leca AP
    Therapie; 1976; 31(3):385-97. PubMed ID: 136767
    [No Abstract]   [Full Text] [Related]  

  • 42. Levamisole in rheumatoid arthritis: a comparison with D-penicillamine.
    Mowat AG; Mowat AM
    J Rheumatol; 1981; 8(4):575-80. PubMed ID: 7299760
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [A case of malignant rheumatoid arthritis associated with myasthenia gravis by D-penicillamine treatment (author's transl)].
    Suzuki H; Imai H; Shiokawa Y
    Ryumachi; 1980 Jun; 20(3):163-70. PubMed ID: 7414431
    [No Abstract]   [Full Text] [Related]  

  • 44. Autoantibody formation in D-penicillamine-treated rheumatoid arthritis.
    Camus JP; Homberg JC; Crouzet J; Mery C; Delrieu F; Massias P; Abuaf N
    J Rheumatol Suppl; 1981; 7():80-3. PubMed ID: 6939887
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Agranulocytosis and myasthenia gravis probably induced by D-penicillamine in rheumatoid patients (author's transl)].
    Hoshi K; Mizushima Y
    Ryumachi; 1981 May; 21(3):234-42. PubMed ID: 7313901
    [No Abstract]   [Full Text] [Related]  

  • 46. Multiple side effects of penicillamine therapy in one patient with rheumatoid arthritis.
    Essigman WK
    Ann Rheum Dis; 1982 Dec; 41(6):617-20. PubMed ID: 6216862
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Myasthenia gravis and D-penicillamine.
    Dawkins RL; Garlepp MJ; McDonald BL; Williamson J; Zilko PJ; Carrano J
    J Rheumatol Suppl; 1981; 7():169-74. PubMed ID: 7014873
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Myasthenia gravis associated with penicillamine treatment for rheumatoid arthritis.
    Bucknall RC; Dixon A St J; Glick EN; Woodland J; Zutshi DW
    Br Med J; 1975 Mar; 1(5958):600-2. PubMed ID: 1125624
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Longterm followup of treatment with D-penicillamine for rheumatoid arthritis: effectivity and toxicity in relation to HLA antigens.
    Moens HJ; Ament BJ; Feltkamp BW; van der Korst JK
    J Rheumatol; 1987 Dec; 14(6):1115-9. PubMed ID: 3437418
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Myasthenia induced by D-penicillamine. Apropos of 2 case reports].
    Huaux JP; Delreux V
    Acta Neurol Belg; 1986; 86(5):297-303. PubMed ID: 3492852
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical evaluation of D-penicillamine by multicentric double-blind comparative study in chronic rheumatoid arthritis.
    Shiokawa Y; Horiuchi Y; Honma M; Kageyama T; Okada T; Azuma T
    Arthritis Rheum; 1977; 20(8):1464-72. PubMed ID: 144507
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genetic markers in rheumatoid arthritis relationship to toxicity from D-penicillamine.
    Stockman A; Zilko PJ; Major GA; Tait BD; Property DN; Mathews JD; Hannah MC; McCluskey J; Muirden KD
    J Rheumatol; 1986 Apr; 13(2):269-73. PubMed ID: 3459889
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Penicillamine-induced myasthenia gravis in a patient with rheumatoid arthritis. A case report.
    Naidoo PD
    S Afr Med J; 1981 Sep; 60(12):478. PubMed ID: 7280897
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intermittent treatment with D-penicillamine is effective in lower doses and with fewer adverse effects in patients with rheumatoid arthritis.
    Hakoda M; Taniguchi A; Kamatani N; Akahoshi T; Kashiwazaki S
    J Rheumatol; 1994 Sep; 21(9):1637-41. PubMed ID: 7799341
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Myasthenic syndrome during treatment with D penicillamine. A recent case].
    Verret JM; Lignac N; Kahn MF
    Ann Med Interne (Paris); 1977; 128(6-7):557-60. PubMed ID: 921113
    [No Abstract]   [Full Text] [Related]  

  • 56. The use of chloroquine and D-penicillamine in the treatment of rheumatoid arthritis.
    Muirden KD
    Med J Aust; 1986 Jan; 144(1):32-4, 36-7. PubMed ID: 2867456
    [No Abstract]   [Full Text] [Related]  

  • 57. Unilateral ptosis as an initial manifestation of D-penicillamine induced myasthenia gravis.
    Raynauld JP; Lee YS; Kornfeld P; Fries JF
    J Rheumatol; 1993 Sep; 20(9):1592-3. PubMed ID: 8164222
    [TBL] [Abstract][Full Text] [Related]  

  • 58. D-Penicillamine-associated myasthenia gravis: immunological and electrophysiological studies.
    Fawcett PR; McLachlan SM; Nicholson LV; Argov Z; Mastaglia FL
    Muscle Nerve; 1982 Apr; 5(4):328-34. PubMed ID: 7099199
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Myasthenia gravis and autoimmune thyroiditis during the treatment of rheumatoid polyarthritis withD-penicillamine. Anatomoclinical study of 1 case].
    Delrieu F; Menkes CJ; Sainte-Croix A; Babinet P; Chesneau AM; Delbarre F
    Ann Med Interne (Paris); 1976 Oct; 127(10):739-43. PubMed ID: 1008366
    [No Abstract]   [Full Text] [Related]  

  • 60. [Myasthenia caused by D-penicillamine in rheumatoid arthritis].
    Héraud A; Dromer C; Fatout E; Fournié B; Fournié A
    Rev Rhum Ed Fr; 1994 Jan; 61(1):59-60. PubMed ID: 8000404
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.